{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:17:35Z","timestamp":1782739055317,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.anndiagpath.2023.152171","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T02:20:39Z","timestamp":1685672439000},"page":"152171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity"],"prefix":"10.1016","volume":"66","author":[{"given":"Tiffany","family":"Javadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan Lee","family":"McLemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin","family":"Oskouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armita","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2023.152171_bb0005","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1056\/NEJMra1607548","article-title":"Langerhans-cell histiocytosis","volume":"379","author":"Allen","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0010","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2010-04-279083","article-title":"Recurrent BRAF mutations in Langerhans cell histiocytosis","volume":"116","author":"Badalian-Very","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0015","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.4049\/jimmunol.0902336","article-title":"Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells","volume":"184","author":"Allen","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2141.2011.08915.x","article-title":"Recent advances in the understanding of Langerhans cell histiocytosis","volume":"156","author":"Badalian-Very","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0025","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0030","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1182\/blood-2014-05-577361","article-title":"High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis","volume":"124","author":"Brown","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0035","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.2019000934","article-title":"Langerhans cell histiocytosis","volume":"135","author":"Rodriguez-Galindo","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.hoc.2015.06.005","article-title":"Clinical characteristics and treatment of Langerhans cell histiocytosis","volume":"29","author":"Monsereenusorn","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0045","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAT.0000000000000256","article-title":"Langerhans cell histiocytosis: a comprehensive review","volume":"47","author":"El Demellawy","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0050","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1111\/cas.13817","article-title":"Langerhans cell histiocytosis in adults: advances in pathophysiology and treatment","volume":"109","author":"Kobayashi","year":"2018","journal-title":"Cancer Sci"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0055","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pbc.21504","article-title":"Incidence of Langerhans cell histiocytosis in children: a population-based study","volume":"51","author":"Stalemark","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0060","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1200\/JCO.2009.22.4295","article-title":"KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial","volume":"27","author":"Richman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0065","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/1097-0142(19951215)76:12<2471::AID-CNCR2820761211>3.0.CO;2-Z","article-title":"Langerhans\u2019 cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases","volume":"76","author":"Kilpatrick","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0070","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.2021014343","article-title":"International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults","volume":"139","author":"Goyal","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1750-1172-8-72","article-title":"Management of adult patients with Langerhans cell histiocytosis: recommendations from an expert panel on behalf of Euro-Histio-Net","volume":"8","author":"Girschikofsky","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cam4.1844","article-title":"Langerhans cell histiocytosis in adults is associated with a high prevalence of hematologic and solid malignancies","volume":"8","author":"Ma","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0085","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0","article-title":"Association of Langerhans cell histiocytosis with malignant neoplasms","volume":"71","author":"Egeler","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0090","first-page":"45","article-title":"The international dataset on the association between Langerhans cell histiocytosis and other malignancies","author":"Bagnasco","year":"2022","journal-title":"Data Brief"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0095","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0959-8049(03)00672-5","article-title":"Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society","volume":"39","author":"Arico","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043257","article-title":"Optimal therapy for adults with Langerhans cell histiocytosis bone lesions","volume":"7","author":"Cantu","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00277-021-04694-7","article-title":"Langerhans cell histiocytosis in adults: a retrospective, single-center case series","volume":"101","author":"Chiaravalli","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41408-022-00685-7","article-title":"Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis","volume":"12","author":"Hu","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0115","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00066-006-1630-9","article-title":"Radiotherapy of Langerhans\u2019 cell histiocytosis: results and implications of a national patterns-of-care study","volume":"182","author":"Olschewski","year":"2006","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0120","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ijrobp.2017.10.053","article-title":"Outcome after radiation therapy for Langerhans cell histiocytosis is dependent on site of involvement","volume":"100","author":"Laird","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1084\/jem.2013097701202015c","article-title":"BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups","volume":"212","author":"Berres","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0130","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/bjh.16099","article-title":"Langerhans cell histiocytosis: progress and controversies","volume":"187","author":"Abla","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0135","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2015.65.9508","article-title":"BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy","volume":"34","author":"Heritier","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.anndiagpath.2023.152171_bb0140","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/10668969221088877","article-title":"A quality analysis of bony specimens for optimal ethylenediaminetetraacetic acid (EDTA) decalcification","volume":"30","author":"Craig","year":"2022","journal-title":"Int J Surg Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913423000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913423000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:35:40Z","timestamp":1761078940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913423000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":28,"alternative-id":["S1092913423000692"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2023.152171","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2023.152171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152171"}}